Conotoxia Review

We conducted a thorough examination of Conotoxia by cross-checking its regulatory credentials against official CySEC registers, analysing real user reviews from multiple platforms, and reviewing aggregated industry complaint data. Our team sought to verify every claim the broker makes about itself against the documented reality. This investigation led to a Scam Risk Score of 32/100 (Guarded), reflecting significant red flags.

Conotoxia Ltd is registered at ChrysorroiaTissis 11, 3032 Limassol, Cyprus, with official incorporation on 12 December 2018. Public records list zero employees, a figure that strongly suggests the company operates with minimal staff, likely relying heavily on outsourced functions or automated systems. While the broker’s own materials claim a 2013 registration under a previous entity, we found no evidence that the current legal entity existed before 2018. This discrepancy is not unusual in the industry but can obscure the true operational history.

The corporate address is a typical Limassol office, not indicative of any special physical presence. A company with zero employees raises questions about its ability to provide adequate support, compliance, and oversight. For a broker handling client funds, such a lean structure is a material risk factor.

Conotoxia holds a single regulatory license from the Cyprus Securities and Exchange Commission (CySEC), number 336/17. This license is categorized as Market Making (MM), meaning the broker can act as the counterparty to client trades rather than routing them to an external market. CySEC is a Tier‑2 EU regulator, and its framework provides client protections such as mandatory segregation of client funds and coverage under the Investor Compensation Fund (ICF) for up to €20,000 in the event of broker insolvency.

While CySEC regulation is a baseline safeguard, it does not guarantee operational integrity. Our checks against the CySEC public register confirmed the license is active, but we noted that the company has not diversified through additional top‑tier licenses (e.g., FCA, BaFin). This limits jurisdictional oversight to Cyprus alone. For EU traders, this may still satisfy MiFID passporting rights, but it also concentrates regulatory risk in a single authority that has been criticized in the past for lax enforcement. The absence of any other regulatory affiliation is a gap that prudent traders should note.

Conotoxia structures its offering around three account tiers—Retail, Experienced, and Professional—aligned with ESMA leverage caps. The Retail account restricts forex leverage to 1:30, which is standard protection for beginners. The Experienced account steps up to 1:100, while the Professional account allows 1:300. To qualify as a Professional, a trader must meet two of three criteria: significant trading activity (e.g., 10 trades per quarter), a portfolio exceeding €500,000, and relevant professional experience in financial services.

Critically, the broker does not disclose minimum deposit requirements for any tier. This opacity makes it impossible to assess the financial barrier to entry. Moreover, there is no information on minimum spreads or commission structures, which are essential for evaluating trading costs. The Professional account’s higher leverage comes without negative balance protection, exposing traders to potentially catastrophic losses. Without transparent cost and deposit data, even experienced traders are flying blind.

Conotoxia does not list any deposit or withdrawal methods on its website or in its legal documents. Typically, CySEC brokers offer bank wire, credit/debit cards, and e-wallets, but without official confirmation, potential clients cannot plan their funding strategy. This lack of transparency is a serious red flag.

Real user reviews paint a dire picture of failed withdrawals and missing deposits. Multiple reviewers describe transfers that have been “in execution” for weeks, with funds effectively vanished. One user reported, “My money did actually vanish,” after a transaction remained stuck since October. Another warned, “they went bankrupt and do NOT process any withdrawals.” Even where the broker’s own FAQ suggests transfers should take less than 8 hours, users report waits of three business days or longer with no communication. These patterns indicate severe operational delays or possible insolvency, raising significant concerns about the safety of client funds.

The broker’s public disclosures list only forex pairs as tradable instruments, but its own marketing materials claim a much broader range: CFDs on indices, shares, ETFs, commodities, cryptos, and futures. We could not independently verify that all these instruments are actually available, as the company provides no detailed product schedule. Such a discrepancy between claims and disclosure suggests either outdated information or deliberate obfuscation.

Similarly, Conotoxia does not name its trading platform. Most CySEC brokers use MetaTrader 4/5 or cTrader, but the absence of any platform mention is unusual. Traders need to know whether they will be trading on a reputable, third-party platform or a proprietary one with unknown reliability. The lack of clarity on both instruments and platform is a serious disadvantage for anyone considering an account.

The broker provides no data on spreads, commissions, or swap rates. Without this information, a cost comparison is impossible. User reviews offer a disturbing glimpse: one client complained of “no clear details on cancellation fees that occur, even when a transaction hasn't taken place yet.” Another had their account blocked “for no reason,” with accusations that hidden fees were being applied. The reported lack of transparency around fees and the aggressive blocking of accounts when users question charges suggest that Conotoxia’s cost structure is both opaque and potentially punitive.

For a trader, unanticipated fees can quickly erode profits or even lead to a forced closure of positions. Combined with the withdrawal issues, these practices create an environment where clients feel trapped and financially exposed.

We analysed 36 Trustpilot reviews and dozens of comments across other platforms. The overwhelming majority are deeply negative, with a Trustpilot rating of 1.5 out of 5. Common themes emerge: funds stuck “in execution” for weeks, accounts blocked after submitting KYC documents, and an almost complete failure of customer support to respond.

One reviewer wrote, “Stay away from this company and its subsidiaries. Over the last year they offer a service that in my language is called stealing.” Another described, “A transfer for a large amount of money I made from UK bank to my wallet on 21st October has vanished into thin air. No response from the company by phone or email.” Allegations of racism and arbitrary account closures also surface: “they blocked me without any notice after I submitted my copy of passport.” A worrying number of users explicitly label the broker a scam, with one stating, “Conotoxia one of the most TOP SCAMMERS I made a transfer on 5 of December and till the moment i didn't receive funds.”

The few positive reviews are mostly older, praising the ease and speed of past transactions. This suggests a sharp deterioration in service quality, consistent with a company facing financial or operational collapse. The recent influx of unresolved complaints aligns with warnings that the broker may be insolvent.

Aggregated industry data aligns with the user reviews. Trustpilot’s 1.5/5 rating places Conotoxia in the bottom tier of broker reputations. The Forex Peace Army has no rating, likely because the broker has not attracted enough trader engagement to generate a profile. Other consumer‑warning databases list Conotoxia with a high number of withdrawal‑related complaints.

When we compare this to similarly CySEC‑regulated firms, the difference is stark. Most reputable Cypriot brokers maintain Trustpilot scores above 3.0 and resolve complaints through the regulator. Conotoxia’s failure to address user grievances, combined with the volume of “scam” allegations, sets it apart as an outlier.

FXCanary assigns Conotoxia a Scam Risk Score of 32/100, placing it in the Guarded category. This score reflects a CySEC license that provides a facade of regulatory cover, undermined by a tiny operational footprint, extreme opacity on costs and funding, and a torrent of user reports describing missing funds, blocked accounts, and stonewalled support.

The real‑world evidence suggests that depositing money with Conotoxia carries a high probability of loss or indefinite delay. The claim of bankruptcy by one reviewer, if true, would mean even the ICF protection may be of limited comfort given the claims process timeline. We cannot recommend this broker to any category of trader.

If you are still considering Conotoxia, proceed with extreme caution. First, verify the CySEC license yourself on the public register and confirm that the entity you are dealing with is indeed the licensed one. Do not rely on the broker’s website for this. Second, never deposit more than you can afford to lose entirely. Even if the company is solvent, the withdrawal freezes reported by users suggest you may not recover your funds for months, if at all.

Document every interaction, including screenshots of your account, transaction IDs, and support requests. If you encounter a delay or denial of withdrawal, immediately file a complaint with the Cyprus Financial Ombudsman. Consider using a broker with a stronger multi‑regulatory footprint and a proven track record of processing withdrawals within standard timeframes.